Noticeboard

The Prize is awarded annually to one young scientist for the most outstanding neurobiological research based on methods of molecular and cell biology conducted during the past three years. Prize money: US$25,000.

Application Deadline: 15th June 2024

Find out more

The Congressionally Directed Medical Research Programs (CDMRP) Amyotrophic Lateral Sclerosis Research Program (ALSRP) has released new FY24 funding opportunities for ALS therapeutic development research.

There are four different awards that can be applied for:

• Pilot Clinical Trial Award
• Clinical Outcomes and Biomarkers Development Award
• Therapeutic Development Award
• Therapeutic Idea Award

Pre-application/letter of intent deadline: 18 June 2024 (5:00 p.m. Eastern Time).

Find out more

The Radala Foundation is looking for established, leading principal investigators eligible for 200,000 CHF research funding to pursue a potentially ground-breaking, high-risk project for 2 years in basic research in ALS. One or two grants of 200,000 Swiss francs will be given each year.
 

Application deadline is on 30 June 2024.
 

Find out more

The National Centre for the Replacement, Refinement and Reduction of animals in Research has announced £4 million of funding is available for infrastructure grants that aim to accelerate the use of non-animal methods. These non-animal methods are ones that could replace the use of animals in research and testing procedures.

This funding call is exclusively for non-research proposals that will focus on increasing the capacity and capabilities of the UK research base to use non-animal methods. 

Application Deadline: 30th July 2024

Find out more

The Frick Foundation is looking for talented early-career scientists who have already produced excellent supervised work, ready to work independently and shows potential to be a research leader. Two researchers will receive 100,000 Swiss francs each that can be used over 2 years. Researchers of any nationality with 5 years of experience since completion of their PhD, a scientific track record showing great promise and an excellent research proposal. Research must be conducted in a public or private research organisation (known as a Host Institution/HI).
 

Application Deadline: 30th September 2024

Find out more

The Healey & AMG Center offers four prizes for innovation in ALS as global awards celebrating advances in research and care: the Sean M. Healey International Prize for Innovation in ALS, the Gupta Family Endowed Prize for Innovation in ALS Care, the Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative Healing, and the Drs. Ayeez and Shelena Lalji & Family Student Scholar Award for Repair and Regenerative Mechanisms in ALS. 

The Sean M. Healey International Prize for Innovation in ALS Research recognizes an individual or a team of investigators who catalyze exceptional discoveries leading to a transformative advance in therapy development in ALS.

Gupta Family Endowed Prize for Innovation in ALS Care is a global prize to honor ground-breaking new approaches that lead to exceptional care for individuals living with ALS.

Drs. Shelena and Ayeez Lalji established the Endowed Award for Innovative Healing to recognize an individual or team of investigators for excellence in their transformative scientific discoveries focused on repair of neurological function in ALS.

Drs. Shelena and Ayeez Lalji established the Student Scholar Award for Repair and Regenerative Mechanisms in ALS to recognize bright young scientists in the field of ALS research facilitating meaningful projects to understand the mechanisms underlying axonal and neuronal repair and regeneration. 

Find out more.

The European Network for the Cure of ALS (ENCALS) aims to develop a European trial network and initiate collaborations in Europe. Membership is open to Universities/Hospitals in Europe with ALS clinical/research activity.

The ENCALS meeting 2024 will be hosted in Stockholm, Sweden on the 17th to 20th June.

Find out more

The 14th International Conference on Frontotemporal Dementias (ISFTD 2024) is scheduled for 19 - 22 September 2024 in Amsterdam, The Netherlands. The conference will cover basic science, through to clinical trials, genetics and clinical research. 

A pre-worshop titled "Defining the FTD & ALS Spectrum" will be held on September 18 (9am to 13pm). This pre-workshop will look into the links between FTD and ALS, which are thought to represent the extreme ends of a complex clinical, pathological, and genetic spectrum.  However, despite the concept of an ALS-FTD spectrum, in practice there remains minimal interaction and consensus between the FTD and ALS research communities. This lack of interaction risks duplicity or inconsistencies in our definitions of the biology and clinical concepts of ALS and/or FTD.  Moreover, TDP-43 which commonly brings together ALS and FTD is also associated with aging and non-CNS disorders which challenge concepts from within our communities. This half-day workshop preceding ISFTD 2024 aims to help us learn from multiple perspectives both within the FTD and ALS communities and beyond. 

Find out more and register

The key to defeating MND lies in fostering strong collaboration between leading researchers around the world, and sharing new understanding of the disease as rapidly as possible. This was the MND Association’s rationale behind the creation of the International Symposium on ALS/MND.

Each year, the Symposium attracts over 1,000 delegates, representing the energy and dynamism of the global MND research community. It is the largest medical and scientific conference specific to MND/ALS and is the premier event in the MND research calendar for discussion on the latest advances in research and clinical management. 

The 35th Symposium will be held in Montreal, Canada from 6-8 December 2024. 

Keep an eye on our Symposium website to find out more over the coming months.